• Francis Fezeu, Cheng-Chia Lee, Blair K Dodson, Sugoto Mukherjee, Colin J Przybylowski, Ahmed J Awad, Zhiyuan Xu, Benjamin Z Ball, Daniel Basuel, David Schlesinger, and Jason P Sheehan.
• Department of Neurological Surgery, University of Virginia , Charlottesville, VA , USA.
• Br J Neurosurg. 2015 Apr 1; 29 (2): 213-8.

ObjectiveFacial nerve schwannomas (FNS) are rare tumors, and their appropriate management remains the subject of considerable debate. This report details the results of a series of patients with FNS treated with stereotactic radiosurgery (SRS) at the University of Virginia.MethodsWe performed a retrospective review of the clinical and imaging outcomes of 5 patients who underwent Gamma Knife RS (GKRS) for small-to-medium-sized (<5 mL) FNS at our institution. The study population consisted of 3 males and 2 females with a median age of 35 years. All patients presented with varying degrees of facial palsy and/or hearing dysfunction. Tumor volumes at GKRS ranged from 0.1 to 5 (median=0.8) mL. The median maximum radiosurgical dose and tumor margin dose were 24 Gy and 12 Gy, respectively.ResultsAfter a median follow-up period of 12 (range, 6-36) months, three tumors were radiographically smaller and two remained stable. Facial function improved in three patients, remained stable in one patient, and slightly declined from House-Brackmann grade I to II in one patient. Hearing function was preserved in three patients and deteriorated in two patients, one from Gardner-Robertson grade I to II and the other from serviceable hearing grade II to III.ConclusionSRS appears to offer a reasonable rate of facial nerve preservation and tumor control for patients with small-to-medium-sized FNS. Considering the published outcomes achieved with resection, RS may be the preferred first-line treatment for these tumors.

23 keywords...

hide…